PetLab Co.

PetLab Co. is a US-based company dedicated to enhancing pet health through innovative dietary supplements and treatments for dogs and cats. Their focus is on delivering effective health solutions for pet owners. Founded in 2018 and headquartered in New York, US, PetLab Co.

specializes in pet health optimization with a diverse range of products. The company has undergone significant development since its inception, focusing on dietary supplements and wellness solutions for pets. In February 2025, BC Partners acquired a majority stake in PetLab Co. Financial terms were not disclosed.

PetLab Co. specializes in pet health optimization products, focusing primarily on dietary supplements and treatments for dogs and cats. Their core offerings include an advanced dental powder, a range of probiotic chews, joint care supplements, and dental sticks specifically formulated to address issues such as bad breath, digestive health, joint mobility, and seasonal allergies. The dental powder, ProBright® Advanced, is clinically studied to reduce plaque buildup and freshen breath, while the probiotic chews enhance gut health and support a healthy inflammatory response.

PetLab Co. 's products are designed for pet parents seeking effective solutions for everyday health challenges faced by their pets. Their geographical footprint spans the United States and international markets where pet health and wellness are prioritized, targeting both direct consumers and retail partners. PetLab Co.

operates primarily on a subscription-based revenue model, emphasizing direct-to-consumer transactions. This model allows customers to receive regular deliveries of their preferred supplements, such as ProBright® Advanced and various probiotic options, at potentially discounted rates. The company also offers standalone purchases through online platforms, which increases accessibility for pet owners. Specific pricing details are associated with their flagship products, with individual items available for purchase at competitive rates.

Furthermore, PetLab Co. has established partnerships with retailers and wholesalers, enhancing its distribution channels and expanding its reach within the pet care industry. This strategic focus on subscriptions and direct sales fosters customer loyalty and repeat business, contributing to a robust revenue stream. PetLab Co.

has plans to expand its product line with new health optimization products targeted for launch in the upcoming year. The company is also looking to enter new geographic markets, specifically targeting growth in Europe and Asia by the end of 2026. The recent acquisition by BC Partners is expected to provide the necessary resources to support these initiatives, enabling PetLab Co. to scale its operations and enhance its product offerings.